Home › Funds › ACORN CAPITAL ADVISORS, LLC › VYNE

ACORN CAPITAL ADVISORS, LLC position in VYNE

YARROW BIOSCIENCES INC

ACORN CAPITAL ADVISORS, LLC reported holding 32,005 shares of VYNE (YARROW BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$721K, representing 0.20% of its reported portfolio and ranking #21 among its reported holdings. ACORN CAPITAL ADVISORS, LLC has disclosed VYNE holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)32.01K sh
Reported value held$720.74K
Portfolio Weight0.20%
First reportedQ4 2024
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How ACORN CAPITAL ADVISORS, LLC's VYNE position evolved

ACORN CAPITAL ADVISORS, LLC first disclosed a stake in VYNE in Q4 2024 at 456,970 shares (US$1.5M). Across 8 filings, ACORN CAPITAL ADVISORS, LLC increased the stake 2 time(s), trimmed it 3 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 32,005 shares valued at US$721K — an increase of 30,580 shares quarter over quarter.. Notable position changes include a 72% increase in Q1 2025, a 100% trim in Q4 2025, a 2146% increase in Q3 2026.

Quarter by quarter

QuarterSharesValueChange
Q4 2024 456.97K $1.53M New
Q1 2025 785.94K $1.24M Add
Q2 2025 736.57K $1.22M Reduce
Q3 2025 586.57K $199.43K Reduce
Q4 2025 1.43K $827 Reduce
Q1 2026 1.43K $855 Hold
Q2 2026 1.43K $926 Hold
Q3 2026 32.01K $720.74K Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VYNE and 13F data

VYNE (YARROW BIOSCIENCES INC) is a company whose sector is not yet classified in our data. 9 other funds we track also report a position in VYNE — the largest reported positions include Lynx1 Capital Management LP (US$1.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VYNE

All VYNE fund holders →

FAQ

How long has ACORN CAPITAL ADVISORS, LLC held VYNE?

ACORN CAPITAL ADVISORS, LLC has disclosed VYNE holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is ACORN CAPITAL ADVISORS, LLC's current position in VYNE?

As of Q3 2026, ACORN CAPITAL ADVISORS, LLC holds 32.01K shares of VYNE (YARROW BIOSCIENCES INC), valued at $720.74K, representing 0.20% of its reported portfolio and ranking #21.

Has ACORN CAPITAL ADVISORS, LLC been buying or selling VYNE?

In the latest 13F filing (Q3 2026), ACORN CAPITAL ADVISORS, LLC increased its position in VYNE.

Which other funds hold VYNE?

Other major institutional holders of VYNE include Lynx1 Capital Management LP, among 9 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.